VIARTRIL-S CAPSULES

Valsts: Malaizija

Valoda: angļu

Klimata pārmaiņas: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

Nopērc to tagad

Lejuplādēt Produkta apraksts (SPC)
15-09-2017

Aktīvā sastāvdaļa:

Glucosamine Sulfate

Pieejams no:

MYLAN HEALTHCARE SDN. BHD.

SNN (starptautisko nepatentēto nosaukumu):

Glucosamine Sulfate

Vienības iepakojumā:

180 Capsules; 80 Capsules; 6 Capsules

Ražojis:

ROTTAPHARM LTD

Produkta apraksts

                                _SM090408CM01 _
VIARTRIL
®
-S
Glucosamine Sulfate
CAPSULES 250 MG
NAME OF THE MEDICINAL PRODUCT
VIARTRIL
®
-S
COMPOSITION
EACH CAPSULE CONTAINS:
_ACTIVE INGREDIENT_
Crystalline glucosamine sulfate
314 mg
_equivalent to: _
_glucosamine sulfate _
_250 mg_
_ _
_sodium chloride _
_64 mg_
_EXCIPIENTS _
Maize starch, Lactose, Magnesium stearate, Talc.
PHARMACEUTICAL FORM AND PRESENTATION
Capsules. Package of 80 and180 capsules.
PHARMACO-THERAPEUTIC GROUP
Product for the treatment of osteoarthritis.
(Product for the musculoskeletal system - ATC code: M01AX05)
MANUFACTURER
ROTTAPHARM Ltd.
Damastown Industrial Park, Mulhuddart
DUBLIN 15 - IRELAND
THERAPEUTIC INDICATIONS
Treatment of the symptoms of osteoarthritis, i.e. pain and function
limitation.
CONTRA-INDICATIONS
Hypersensitivity to glucosamine or to any of the excipients.
As the active ingredient is obtained from seafood (shellfish), the
product should not be
given to patients who are allergic to shellfish.
PRECAUTIONS FOR USE
This medicinal product contains 50 mg of sodium per dose. The daily
sodium intake is 150
mg. To be taken into consideration by patients on a controlled sodium
diet. The
administration in patients with severe hepatic or renal insufficiency
should be made under
medical supervision.
SPECIAL WARNINGS
The animal studies did not evidence any unfavourable effects on the
reproductive
functions or on lactation. In the absence of such studies in humans,
the product during
pregnancy and lactation should be used only under medical control.
Administration during
the first three months of pregnancy must be avoided.
No effects on the ability to drive or to operate machines is expected.
_ _
POSOLOGY AND METHOD OF ADMINISTRATION
2 capsules taken three times daily, preferably at meals.
OVERDOSE
No cases of accidental or intentional overdose are known. The animal
acute and chronic
toxicological studies indicate that toxic effects and symptoms of
toxicity are not likely to
occur, even after high overdoses.
UNDESIRABLE EFFECTS
The clinical trials have shown the g
                                
                                Izlasiet visu dokumentu
                                
                            

Meklēt brīdinājumus, kas saistīti ar šo produktu

Skatīt dokumentu vēsturi